Concepedia
Statistics
Publications
71
Citations
7.3K
Authors
12
Location
Seattle, United States
Kineta (United States) is a company institution in Seattle, United States known for immunology, medicine, and pathogenesis.
Top concepts
MedicineImmunologyPathogenesisVirologyVaccinationMicrobiologyCross-protectionInfluenza VaccinesViral PathogenesisVaccine Development
Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain
Haylie Romero, Sean Christensen, Lorenzo Di Cesare Mannelli et al. · Proceedings of the National Academy of Sciences · 2017 · 159 citations · Full text
Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial
Eric J. Tarcha, Chelsea M. Olsen, Peter Probst et al. · PLoS ONE · 2017 · 156 citations · Full text
Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease
Eric J. Tarcha, Victor Chi, Ernesto J. Muñoz‐Elías et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 114 citations · Full text
Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance
S. Upadhyay, Kristin Eckel‐Mahan, Mohammadreza Mirbolooki et al. · Proceedings of the National Academy of Sciences · 2013 · 89 citations · Full text
Kv1.3 channel‐blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases
Sandeep Chhabra, Shih Chieh Chang, Hai M. Nguyen et al. · The FASEB Journal · 2014 · 88 citations · Full text
Rows per page
1–5 of 71
Kineta (United States), United States
70 publications · 1.9K citations
20
h-index
34 publications · 1K citations
21 publications · 593 citations
6
15 publications · 51 citations
3
11 publications · 42 citations
1–5 of 12